Erschienen in:
17.03.2016 | Editorial
New Targets and New Treatments: Recent Advances in the Treatment of Musculoskeletal Disease
Erschienen in:
Calcified Tissue International
|
Ausgabe 4/2016
Einloggen, um Zugang zu erhalten
Excerpt
Over the past two decades, huge strides have been made in understanding the genes and molecular pathways that contribute to the pathogenesis of bone and muscle diseases. As a result of these advances, several new molecular targets have been identified for drug design and this knowledge is now being harnessed by the pharmaceutical industry to develop new drugs for the treatment of sarcopenia and metabolic bone diseases like osteoporosis, hypophosphataemic rickets, and hypophosphatasia. The current issue of Calcified Tissue International and Musculoskeletal Research highlights some of the most notable advances that have occurred in this fast developing area over recent years. …